Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates-Reference-Cited by-同舟云学术

Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates

Published:2015-01-14 Issue:3 Volume:45 Page:854-864
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Li Jessica¹²,Ahmet Fatma¹,Sullivan Lucy C.²,Brooks Andrew G.²,Kent Stephen J.²,De Rose Robert²,Salazar Andres M.³,Reis e Sousa Caetano⁴,Shortman Ken¹⁵⁶,Lahoud Mireille H.¹⁷,Heath William R.²,Caminschi Irina¹²

Affiliation:

1. Centre for Biomedical Research; Burnet Institute; Melbourne Victoria Australia

2. Department of Microbiology and Immunology; Peter Doherty Institute for Infection and Immunity; The University of Melbourne; Victoria Australia

3. OncoVir; Oncovir Inc. NW; Washington DC USA

4. Immunobiology; Cancer Research UK; London Research Institute; London UK

5. The Walter and Eliza Hall Institute of Medical Research; Victoria Australia

6. Department of Medical Biology; University of Melbourne; Parkville Victoria Australia

7. Department of Immunology; Monash University; Melbourne Australia

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Reference27 articles.

1. Targeting dendritic cells in vivo for cancer therapy;Caminschi;Front. Immunol.,2012

2. Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity;Trumpfheller;J. Intern. Med.,2012

3. Designing vaccines based on biology of human dendritic cell subsets;Palucka;Immunity,2010

4. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting;Tacken;Nat. Rev. Immunol,2007

5. Boosting antibody responses by targeting antigens to dendritic cells;Caminschi;Trends Immunol.,2011

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immunity in mice;Molecular Therapy;2024-07

2. A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses;Frontiers in Immunology;2024-02-02

3. Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design;Frontiers in Immunology;2023-11-27

4. Recombinant antigen delivery to dendritic cells as a way to improve vaccine design;Experimental Biology and Medicine;2023-09-25

5. Cell-targeted vaccines: implications for adaptive immunity;Frontiers in Immunology;2023-08-16